Key result
Cardiac resynchronization therapy is becoming a valuable tool in the treatment of ventricular dyssynchrony and dilated cardiomyopathy in pediatric and congenital heart disease patients.
Why the study?
Does cardiac resynchronization therapy improve outcomes in pediatric and congenital heart disease patients with ventricular dyssynchrony and dilated cardiomyopathy?
Population
Pediatric and congenital heart disease patients with ventricular dyssynchrony and dilated cardiomyopathy
Design
Review
Authors
Loading...
Supports CRT evaluation in pediatric CHD with dyssynchrony; leaves open need for prospective trials to confirm outcomes.
Does cardiac resynchronization therapy improve outcomes in pediatric and congenital heart disease patients with ventricular dyssynchrony and dilated cardiomyopathy?
CRT is increasingly recognized as a valuable and feasible therapy for pediatric and congenital heart disease patients with ventricular dyssynchrony and dilated cardiomyopathy.
Greene et al. (2010) conducted a review in Dilated cardiomyopathy and ventricular dyssynchrony in pediatric and congenital heart disease. Cardiac resynchronization therapy (CRT) was evaluated. Cardiac resynchronization therapy is becoming a valuable tool in the treatment of ventricular dyssynchrony and dilated cardiomyopathy in pediatric and congenital heart disease patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: